Astera Labs (ALAB) COO’s 90,630-share tax sale detailed
Astera Labs, Inc. (ALAB) President and COO Gajendra Sanjay sold 90,630 shares of common stock on August 17, 2026. These sales were not discretionary and were executed automatically under a "sell to cover" arrangement to satisfy tax withholding obligations from vested restricted stock units. The weighted-average sale prices ranged from approximately $333.60 to $352.11 per share.
Astera Labs president & COO sells $30.8m in shares
Astera Labs President and COO, Sanjay Gajendra, sold approximately $30.8 million worth of company stock to cover tax withholding obligations from restricted stock unit vesting. Following these sales, Gajendra retains significant direct and indirect holdings in Astera Labs. The company recently reported strong Q2 2026 earnings and received upgraded ratings from Northland and Needham.
Credo vs. Astera Labs: Which AI Connectivity Stock Is the Better Buy?
This article compares Credo Technology Group (CRDO) and Astera Labs (ALAB), two prominent AI connectivity stocks, for investors seeking to capitalize on the artificial intelligence infrastructure boom. It delves into their fundamentals, valuations, growth outlooks, and risks, concluding that Astera Labs, with its "Strong Buy" Zacks Rank, appears to be the better pick at present due to its robust growth and expanding market opportunities in AI connectivity.
Danske Bank A S Makes New Investment in Astera Labs, Inc. $ALAB
Danske Bank A S has made a new investment in Astera Labs, Inc. (NASDAQ:ALAB), acquiring 69,100 shares valued at approximately $33.4 million in the second quarter. The company has a "Moderate Buy" consensus rating from analysts, with strong revenue growth of 104.5% year-over-year and earnings exceeding expectations, driven by high demand for AI-connectivity solutions. However, the stock exhibits high volatility and a valuation above 140 times earnings, and some insiders have sold shares to cover tax obligations.
Astera Labs CEO Jitendra Mohan sells $30.8m in common stock
Astera Labs CEO Jitendra Mohan sold approximately $30.8 million worth of common stock on August 17, 2026, in a "sell to cover" transaction for tax obligations, not a discretionary trade. Following the sale of 86,180 shares, Mohan directly holds 1,266,665 shares and indirectly controls 6,789,233 shares. Despite the sale, Astera Labs reported strong Q2 2026 earnings with record revenue and analyst upgrades, although its stock is currently considered overvalued by InvestingPro.
Mitsubishi UFJ Asset Management Co. Ltd. Purchases Shares of 202,725 Astera Labs, Inc. $ALAB
Mitsubishi UFJ Asset Management Co. Ltd. has acquired 202,725 shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, valued at approximately $97.9 million, giving it a 0.12% stake. This comes as institutional investors collectively own 60.47% of Astera Labs, and the company recently reported stronger-than-expected quarterly results. Despite a recent 5.2% stock decline and insider share sales, analysts maintain a "Moderate Buy" rating with an average price target of $333.
Astera Labs, Inc. $ALAB Shares Sold by Timothy G. Youngquist 2020 Irrevocable Trust
Timothy G. Youngquist 2020 Irrevocable Trust reduced its stake in Astera Labs (ALAB) by 59.5% in the second quarter, selling 7,923 shares but retaining 5,395 shares valued at $2.61 million. This occurred despite other institutional investors increasing their exposure and Astera Labs reporting strong Q2 earnings with $0.80 EPS and $392.4 million in revenue, exceeding analyst expectations. The stock currently has a "Moderate Buy" consensus rating with an average price target of $333.
ALAB vs. AVGO: Which AI Infrastructure Stock Is the Better Buy Now?
This article compares Astera Labs (ALAB) and Broadcom (AVGO) as investments in the AI infrastructure market, focusing on their growth, financial performance, and market position. While both companies are benefiting from the booming AI sector, Astera Labs is presented as a more attractive option due to its stronger growth prospects, rising earnings estimates, and robust demand for its connectivity solutions. Broadcom, despite its significant AI growth, faces challenges such as higher debt, customer concentration, and competitive pressures.
Why Is Astera Labs Stock Surging Monday?
Astera Labs (NASDAQ: ALAB) stock surged Monday following an upgrade from Northland Capital Markets to Outperform with a $350 price target. This upgrade comes after the company reported better-than-expected second-quarter results and issued a strong third-quarter outlook, surpassing analyst estimates for both earnings and revenue. The stock's technical analysis shows a mixed picture with longer-term bullish trends despite some near-term pressure.
TimesSquare Capital Management LLC Acquires Shares of 175,869 Astera Labs, Inc. $ALAB
TimesSquare Capital Management LLC has acquired 175,869 shares of Astera Labs, Inc. (ALAB) for approximately $84.9 million, making it their 21st-largest holding. This comes as Astera Labs reported strong quarterly earnings and revenue, exceeding analyst estimates. Despite broad optimism from analysts, company insiders have sold a significant number of shares recently.
BlackRock Inc. Makes New Investment in Astera Labs, Inc. $ALAB
BlackRock Inc. has made a significant new investment in Astera Labs (NASDAQ:ALAB) during the second quarter, purchasing over 13.6 million shares valued at approximately $6.6 billion, now owning 7.98% of the company. Other institutional investors have also adjusted their holdings, while several analysts have issued positive ratings and increased price targets for ALAB. Insider activity shows recent stock sales by directors, though company insiders still hold a substantial portion of the stock.
Buckland Partners Management Co LLC Invests $5.31 Million in Astera Labs, Inc. $ALAB
Buckland Partners Management Co LLC has invested $5.31 million in Astera Labs, Inc. (NASDAQ:ALAB) by purchasing 11,000 shares in the second quarter, making it their 6th biggest holding and representing 2.6% of their portfolio. This investment follows Astera Labs' strong quarterly results, with earnings beating analyst expectations and revenue increasing by 104.5% year over year. Despite a "Moderate Buy" consensus from analysts, company insiders have sold a significant amount of stock recently, totaling $215.5 million over the past three months.
Astera Labs Inc Stock (ALAB) Opened Up by 7.14% on Aug 17: Key Drivers Unveiled
Astera Labs Inc (ALAB) stock rose 7.14% on August 17, driven by an upgrade from Northland Securities to "Outperform" with a higher price target, citing strong AI infrastructure investment and market share gains. The company reported record quarterly revenue, doubling year-over-year, and issued optimistic forward guidance for its Scorpio and Aries product lines. Despite strong performance, the stock faces risks including an extreme valuation multiple, high customer concentration, and substantial insider selling.
Astera Labs (NASDAQ:ALAB) Growth Story Gets More Interesting
Astera Labs is gaining market attention due to its strengthened position in AI infrastructure, driven by increasing data-center connectivity demand and strong quarterly performance. The company specializes in high-speed connectivity solutions crucial for advanced AI systems, where efficient data movement and reliable communication are paramount. While rapid expansion creates enthusiasm, Astera Labs must continue to demonstrate durable operating strength amidst competition and evolving customer spending plans.
Northland upgrades Astera Labs stock rating on AI spending outlook
Northland upgraded Astera Labs (NASDAQ:ALAB) to Outperform from Market Perform, setting a price target of $350 due to an anticipated extended AI infrastructure spending cycle and positive earnings revisions. The firm highlighted Astera Labs' strong position in AI infrastructure signal conditioning and its significant revenue growth. Recent financial results and new funding commitments for AI infrastructure from major tech and financial players further support this optimistic outlook, suggesting the AI spending peak will extend into 2027.
Wealth Effects LLC Buys Shares of 14,490 Astera Labs, Inc. $ALAB
Wealth Effects LLC recently acquired 14,490 shares of Astera Labs, Inc. (ALAB) for approximately $7 million, making it their 11th largest holding. Despite significant insider selling totaling $292.4 million in the last quarter, Astera Labs received a "Moderate Buy" consensus rating from analysts, with an average price target of $325.25. The company reported strong Q2 earnings, beating estimates with $0.80 EPS and revenue of $392.4 million, up 104.5% year-over-year.
J.Safra Asset Management Corp Buys Shares of 3,447 Astera Labs, Inc. $ALAB
J.Safra Asset Management Corp has acquired 3,447 shares of Astera Labs, valued at approximately $1.665 million, marking a new position for the firm. This comes as institutional investors now hold 60.47% of the company, despite significant insider selling totaling over $292 million in the last quarter. Astera Labs recently reported strong financial results, surpassing EPS and revenue estimates, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $325.25.
8,193 Shares in Astera Labs, Inc. $ALAB Bought by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. acquired 8,193 shares of Astera Labs (NASDAQ:ALAB) in the second quarter, valued at approximately $3.96 million. Institutional investors now own 60.47% of the company, which recently reported stronger-than-expected quarterly results. Despite a "Moderate Buy" consensus from analysts, insiders have sold a significant amount of shares over the past 90 days.
Can Astera Labs (ALAB) Justify Its Valuation As Strong Results And Guidance Land?
Astera Labs (ALAB) has delivered strong Q3 2026 guidance and earnings, leading to significant share price gains year-to-date. Despite its current valuation being deemed "undervalued" by one narrative at $391.77 versus its $321.61 closing price, its high P/S ratio of 46.4x suggests a premium valuation with little room for error. Investors are now weighing the company's strong momentum and long-term potential in AI infrastructure against its current market price.
Can Astera Labs (ALAB) Justify Its Valuation As Strong Results And Guidance Land?
Astera Labs (ALAB) has released strong earnings and guidance for Q3 2026, leading investors to re-evaluate its valuation. While the company's shares have shown significant momentum recently, a "most followed narrative" suggests the stock is 17.9% undervalued, setting a fair value of $391.77 based on aggressive AI infrastructure expectations. However, another view highlights a high P/S ratio of 46.4x, which is significantly above industry averages, indicating little room for error and split sentiment among investors regarding its future prospects.
Does Astera Labs, Inc. (ALAB) Have the Potential to Rally 30.45% as Wall Street Analysts Expect?
Astera Labs, Inc. (ALAB) shares have seen a 1% gain in the past month, with Wall Street analysts projecting a potential upside of 30.5%, bringing the mean target to $421.06. While price targets can be misleading, strong agreement among analysts and positive earnings estimate revisions, combined with a Zacks Rank #1 (Strong Buy), suggest a potential rally for the stock. Investors are advised to consider these factors alongside the inherent skepticism regarding analyst price targets.
Does Astera Labs, Inc. (ALAB) Have the Potential to Rally 30.45% as Wall Street Analysts Expect?
Astera Labs, Inc. (ALAB) has seen its stock gain 1% recently, with Wall Street analysts projecting a potential upside of 30.5% based on an average price target of $421.06. Despite skepticism surrounding analyst price targets, a strong consensus among analysts regarding the company's earnings potential and a Zacks Rank #1 (Strong Buy) suggest a legitimate upside. Investors are advised to consider earnings estimate revisions as a more reliable indicator than price targets alone.
Buy Astera Labs, Inc. (XALAB) with credit card | How to Buy Astera Labs, Inc.
This article from OKX Europe provides a comprehensive guide on how to buy Astera Labs, Inc. (XALAB) using various payment methods such as credit/debit cards, PayPal, Apple Pay, and bank transfers. It emphasizes OKX's security features, high liquidity, transparency, and user-friendliness, while also advising users on important considerations like market trends, risk tolerance, and regulatory developments before making a purchase.
7,574 Shares in Astera Labs, Inc. $ALAB Bought by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. has acquired 7,574 shares of Astera Labs, Inc. (NASDAQ:ALAB) for approximately $3.66 million, marking a new position for the institutional investor. This move comes amidst Astera Labs' strong quarterly performance, with revenue increasing by 104.5% year-over-year and EPS beating analyst expectations. Despite positive outlooks driven by AI infrastructure demand and AMD's ecosystem expansion, the stock faces high valuation risks and recent insider selling.
Astera Labs, Inc. (NASDAQ:ALAB) Given Average Recommendation of "Moderate Buy" by Analysts
Analysts have issued a "Moderate Buy" rating for Astera Labs (NASDAQ:ALAB), with 13 buy recommendations and 10 hold ratings, and an average 12-month price target of $325.25. The company demonstrated strong operating momentum, with revenue up 104.5% year-over-year and EPS exceeding estimates, driven by demand for PCIe connectivity and AI infrastructure. However, risks include a high valuation (P/E ratio above 150) and recent insider stock sales totaling $362.8 million.
Astera Labs Inc Stock (ALAB) Moved Up by 6.11% on Aug 12: Key Drivers Unveiled
Astera Labs Inc (ALAB) saw its stock price increase by 6.11% on August 12, driven by strong quarterly financial results that surpassed expectations and robust demand for its semiconductor connectivity solutions in AI infrastructure. Analyst upgrades and positive market sentiment surrounding AI deployment also contributed to the upward momentum. Despite positive indicators, the article notes potential risks including gross margin compression, cash reserve drain, insider stock sales, and reliance on hyperscale cloud providers.
Astera Labs (NASDAQ:ALAB) Shares Gap Up - Should You Buy?
Astera Labs (NASDAQ:ALAB) shares gapped up by 6.6% to $334.49, driven by optimism for AI connectivity products and strong financial results including 104.5% year-over-year revenue growth. Northland Securities significantly raised its earnings forecasts for the company, while AMD's Helios AI systems are anticipated to provide further growth. Despite strong performance and a "Moderate Buy" consensus from analysts, investors should consider the stock's high valuation (P/E ratio of 164.59) and significant insider selling.
ALAB Benefits From PCIe Demand: Can It Stay Ahead of Its Competitors?
Astera Labs (ALAB) is experiencing significant growth due to high demand for PCIe solutions, especially in AI infrastructure, with record revenues in Q2 2026 and strong projections for Q3. The company's diverse product portfolio and focus on next-generation technologies like PCIe 6, UALink, and optical connectivity are key strengths against competitors like Marvell Technology (MRVL) and Credo Technology Group (CRDO). While ALAB's shares have surged and it holds a "Strong Buy" Zacks Rank, it faces stiff competition and trades at a premium valuation.
Astera Labs Posted 104% Revenue Growth in Q2. Why Is ALAB Down From Its Highs?
Astera Labs (ALAB) reported strong Q2 revenue growth of 104% year-over-year, beating analyst expectations, and provided optimistic Q3 guidance. Despite this strong performance and raised analyst targets, the stock is down from its highs, trading at a high valuation multiple. The company's growth drivers include its Scorpio AI fabric switch and PCIe 6 products, but insider selling and a demanding valuation pose risks.
Astera Labs Inc (Derivatives): Latest News, Social Media Updates and Insights
This article provides the latest news and social media updates for Astera Labs Inc (Derivatives). It highlights that 12 Nasdaq 100 stocks, including Sandisk, have more than doubled in 2026, with none of them being part of the "Magnificent Seven" group. The article also lists Astera Labs Inc (Derivatives) current price at $318.87.
Astera Labs, Inc. (ALAB) Stock Price, News, Quote & History
This page provides a comprehensive overview of Astera Labs, Inc. (ALAB) stock, including its current price, historical data, key financial metrics, and analyst insights. The stock closed at $311.99 on August 11, with pre-market trading showing a rise to $318.03. Astera Labs specializes in semiconductor-based connectivity solutions for cloud and AI infrastructure.
Astera Labs vs. Arm: Which Technology Stock Is a Better Buy in 2026?
This article compares Astera Labs and Arm Holdings, two technology stocks crucial to the AI ecosystem, to determine which might be a better investment by 2026. While Arm licenses processor architectures and boasts a dominant market position, Astera Labs provides high-growth connectivity solutions for AI data centers. The author concludes that Astera Labs, despite its risks, offers greater upside due to its faster revenue growth and expanding margins compared to Arm.
Stefan Dyckerhoff Sells 8,994 Shares of Astera Labs (NASDAQ:ALAB) Stock
Astera Labs Director Stefan Dyckerhoff sold 8,994 shares of the company's stock for approximately $2.8 million on August 6th, reducing his direct holdings by nearly 70%. Despite this insider sale, Astera Labs reported strong quarterly earnings, beating analyst expectations with $0.80 EPS and $392.4 million in revenue, a 104.5% year-over-year increase. The stock currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $325.25.
Astera Labs (ALAB) director Stefan Dyckerhoff sells 12,499 shares under 10b5-1 plan
Astera Labs director Stefan A. Dyckerhoff sold 12,499 shares of common stock on August 6, 2026, through multiple open-market transactions. These sales were conducted at weighted average prices between $309 and $313 per share, according to a Rule 10b5-1 trading plan established on December 1, 2025. The shares were held directly and indirectly through various trusts and a limited partnership.
Astera Labs, Inc. $ALAB Shares Sold by StoneCrest Wealth Management Inc.
StoneCrest Wealth Management Inc. significantly reduced its stake in Astera Labs (NASDAQ:ALAB) by 91.8% in the second quarter, selling 6,569 shares and retaining 584 shares valued at $282,000. Despite this, institutional investors collectively own 60.47% of ALAB, and the company reported strong Q2 earnings, exceeding analyst expectations with an EPS of $0.80 and revenue of $392.4 million. Analyst sentiment remains largely positive, with a "Moderate Buy" consensus, although the average price target is slightly below the stock's opening price.
Why Astera Labs (ALAB) Is Up 7.4% After Surging Q2 Results And Upbeat Q3 Guidance
Astera Labs (ALAB) saw its stock rise 7.4% following strong second-quarter 2026 results, reporting significant increases in sales and net income. The company also issued optimistic third-quarter 2026 guidance, projecting higher revenues and GAAP diluted EPS, driven by demand for AI and data center connectivity. This performance reinforces the company's investment narrative, though dependence on a few large customers and rapid technology shifts remain key risks.
Astera Labs, Inc. $ALAB Shares Sold by Royal Bank of Canada
Royal Bank of Canada decreased its stake in Astera Labs (NASDAQ:ALAB) by 21.6% in the first quarter, selling 36,506 shares but still holding 132,292 shares valued at $14.5 million. Despite institutional investors owning 60.47% of the company, insiders sold 1.24 million shares worth approximately $358.9 million during the same period. Analysts maintain a "Moderate Buy" rating with an average price target of $325.25, following Astera Labs' strong quarterly earnings report where EPS of $0.80 beat estimates and revenue surged by 104.5%.
MRA Advisory Group Makes New Investment in Astera Labs, Inc. $ALAB
MRA Advisory Group has made a new investment in Astera Labs, Inc. (NASDAQ:ALAB), acquiring 3,594 shares valued at approximately $1.74 million during the second quarter. Astera Labs recently surpassed quarterly earnings expectations, reporting $0.80 EPS on $392.4 million revenue, and provided optimistic Q3 2026 EPS guidance. Despite significant insider sales, analysts maintain a "Moderate Buy" rating for the company.
Astera Labs Inc Stock (ALAB) Moved Up by 5.30% on Aug 6: Drivers Behind the Movement
Astera Labs Inc. (ALAB) stock rose 5.30% due to strong institutional demand for AI connectivity hardware and upward revisions of price targets by analysts. The company benefits from its dominant market share in high-speed signal integrity technology solutions, addressing data bottlenecks in AI infrastructure. Despite positive momentum, risks include customer concentration, competitive margin compression, and heightened valuation sensitivity.
Should Investors Hold on to Astera Labs Stock Post Q2 Earnings?
Astera Labs (ALAB) shares have fallen 12% since its Q2 2026 earnings report, primarily due to higher operating expenses despite strong demand for its AI connectivity products. The company's stock has outperformed the broader tech sector year-to-date, driven by its Scorpio, Aries, and Taurus product families, and it projects strong Q3 2026 revenue and earnings growth. However, Astera Labs faces significant competition from companies like Marvell Technology, Cisco Systems, and Credo Technology, and its stock is currently trading at a premium valuation.
Astera Labs, Inc. (ALAB): New Buy Recommendation for This Technology Giant
Jefferies analyst Blayne Curtis maintained a Buy rating on Astera Labs, Inc. (ALAB) with a price target of $450.00, following strong Q1 earnings where the company reported $308.36 million in revenue and $80.31 million in net profit. While Roth MKM also issued a Buy rating, Susquehanna maintained a Hold. Despite positive analyst sentiment, corporate insider activity shows an increase in share selling over the past quarter.
Astera Labs, Inc. Stock 12‑Month Price Target Raised to $391.01, Implies 8% Upside
Astera Labs, Inc. (ALAB) has seen its average 12-month price target raised to $391.01 by 21 analysts, suggesting an 8% upside from its Aug. 4 closing price. The consensus rating for the stock remains a "Buy" from 24 analysts, with a breakdown of 15 Buys, 8 Holds, and 1 Sell.
Astera Labs and Amphenol: Quiet AI Capex Tax Collectors to Know Before Others Catch On
The article analyzes Astera Labs (ALAB) and Amphenol (APH) as beneficiaries of AI infrastructure spending. Astera Labs, focused on AI fabric silicon, saw revenue double year over year, while Amphenol, with diversified offerings, grew 55% to $8.76 billion. The author suggests Astera offers higher growth potential but Amphenol provides a steadier compounding profile due to its diversified markets and strong free cash flow.
Astera Labs Inc reports results for the quarter ended June 30 - Earnings Summary
Astera Labs Inc has released its earnings summary for the quarter that ended on June 30. The article is a brief announcement from Reuters, indicating the availability of the full report for subscribers on TradingView.
Astera Labs price target raised to $450 from $270 at Jefferies
Jefferies analyst Blayne Curtis increased the price target for Astera Labs (ALAB) to $450 from $270, maintaining a Buy rating on the shares. This upgrade follows Astera Labs' strong Q2 performance and a "substantial" Q3 earnings guidance raise, which is 50% above consensus estimates. The firm anticipates further raises driven by the inflection of Scorpio X and the ramp-up of scale-up networking.
ALAB Q2 Earnings Call Puts Scorpio Ramp Ahead of Schedule
Astera Labs (ALAB) reported strong Q2 2026 earnings, beating analyst estimates, and announced that its Scorpio fabric switch production ramp is ahead of schedule, leading to an anticipated sharp increase in Q3 revenue. The company also highlighted continued growth drivers beyond switching, including Aries demand, CXL wins, optical connectivity, and custom silicon, positioning it for further expansion in 2027 and beyond. Management expects significant operating leverage as revenue grows and plans to support future XPU platforms with new products.
SPCX, AMD, NVDA, ALAB, AMIX: 5 Trending Stocks Today - Advanced Micro Devices (NASDAQ:AMD)
On Tuesday, major U.S. stock indexes closed higher, with the Dow Jones, S&P 500, and Nasdaq all seeing significant gains. This article highlights five trending stocks that captured investor attention: SpaceX (SPCX), Advanced Micro Devices (AMD), Nvidia (NVDA), Astera Labs (ALAB), and Autonomix Medical (AMIX). Each company's stock performance, key news, and financial updates for the day are detailed.
Astera Labs Stock Shoots Higher After Q2 Earnings — Here's Why
Astera Labs (NASDAQ:ALAB) reported impressive Q2 2026 earnings, surpassing analyst expectations for both revenue and adjusted earnings per share. The company posted a record revenue of $392.4 million, demonstrating significant sequential and year-over-year growth, driven by strong performance across its product portfolio. Following the announcement, Astera Labs stock saw a notable increase in extended trading.
Astera Labs Reports Second Quarter 2026 Financial Results
Astera Labs (Nasdaq: ALAB) announced record Q2 2026 financial results, with revenue of $392.4 million, up 27% quarter-over-quarter and 104% year-over-year. The company attributes this growth to diversified strength in AI fabrics and signal conditioning, with expectations for accelerated momentum in Q3 driven by its Scorpio™ X-Series 320-lane fabric switch production ramp. Astera Labs also provided Q3 2026 financial outlook, projecting revenue between $540 million and $560 million.
Astera Labs earnings on deck: Can AI chip rally continue? By Investing.com
Astera Labs is set to report Q2 earnings, with investors keen to see if the AI connectivity chip maker can maintain its strong growth, despite moderated analyst expectations. The company, a key supplier in AI infrastructure, faces scrutiny on exceeding guidance, gross margins, and early traction for its new Scorpio X-Series switch. Its stock has seen significant rebound but analysts foresee modest downside from current levels.
